new concern over Adderall (mixed amphetamines)

March 2005

There's a new concern over Adderall (mixed amphetamines).

Canadian authorities suspended sales of Adderall XR...due to 20 reports of sudden death in children and adults.

But the FDA says that some of these deaths occurred in patients with structural heart abnormalities...and the risk doesn't seem to be significantly different than for patients taking methylphenidate.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

figuring out the actual risk of COX-2 inhibitors
Sudafed PE, a new version that DOESN'T contain pseudoephedrine
Are all inhalation devices equally effective
Cardiology concerns about Plavix and GI bleeding
Insomnia a new sleeping pill called Lunesta
new concern over Adderall (mixed amphetamines)
guidelines for treating migraines in CHILDREN
Neurology & Pain Palladone, the first long-acting oral hydromorphone
Gastroenterology whether chronic use of stimulant laxatives is harmful
Gastroenterology Is it important for patients to avoid aspirin and NSAIDs before fecal occult blood tests (Hemoccult, etc)
Gastroenterology if drug doses need to be different after gastric bypass surgery
Dermatology benzoyl peroxide often works as well as oral minocycline for mild to moderate facial acne
HIV & AIDS new recommendations for preventing HIV immediately AFTER an exposure
Drug Testing People are asking about drug testing

new concern over Adderall (mixed amphetamines)

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents